Bonavida Victor, Ghassemi Kaitlyn, Ung Gwendolyn, Inouye Keiko, Thankam Finosh G, Agrawal Devendra K
Department of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Rev Cardiovasc Med. 2022 Nov 30;23(12):392. doi: 10.31083/j.rcm2312392. eCollection 2022 Dec.
With heart failure (HF) being one of the leading causes of hospitalization and death worldwide, multiple stem cell therapies have been attempted to accelerate the regeneration of the infarct zone. Versatile strategies have emerged to establish the cell candidates of cardiomyocyte lineage for regenerative cardiology. This article illustrates critical insights into the emerging technologies, current approaches, and translational promises on the programming of diverse cell types for cardiac regeneration.
心力衰竭(HF)是全球住院和死亡的主要原因之一,人们尝试了多种干细胞疗法来加速梗死区域的再生。为再生心脏病学建立心肌细胞谱系的细胞候选物,已经出现了多种策略。本文阐述了对新兴技术、当前方法以及将多种细胞类型编程用于心脏再生的转化前景的关键见解。